全文获取类型
收费全文 | 2003篇 |
免费 | 121篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 45篇 |
妇产科学 | 68篇 |
基础医学 | 247篇 |
口腔科学 | 36篇 |
临床医学 | 99篇 |
内科学 | 564篇 |
皮肤病学 | 34篇 |
神经病学 | 143篇 |
特种医学 | 74篇 |
外科学 | 392篇 |
综合类 | 16篇 |
预防医学 | 163篇 |
眼科学 | 24篇 |
药学 | 92篇 |
中国医学 | 5篇 |
肿瘤学 | 125篇 |
出版年
2023年 | 15篇 |
2022年 | 23篇 |
2021年 | 69篇 |
2020年 | 44篇 |
2019年 | 39篇 |
2018年 | 55篇 |
2017年 | 41篇 |
2016年 | 57篇 |
2015年 | 53篇 |
2014年 | 58篇 |
2013年 | 90篇 |
2012年 | 125篇 |
2011年 | 149篇 |
2010年 | 82篇 |
2009年 | 64篇 |
2008年 | 121篇 |
2007年 | 114篇 |
2006年 | 91篇 |
2005年 | 116篇 |
2004年 | 91篇 |
2003年 | 86篇 |
2002年 | 81篇 |
2001年 | 38篇 |
2000年 | 27篇 |
1999年 | 48篇 |
1998年 | 29篇 |
1997年 | 27篇 |
1996年 | 21篇 |
1995年 | 18篇 |
1994年 | 15篇 |
1993年 | 16篇 |
1992年 | 27篇 |
1991年 | 19篇 |
1990年 | 20篇 |
1989年 | 18篇 |
1988年 | 19篇 |
1987年 | 10篇 |
1986年 | 17篇 |
1985年 | 16篇 |
1984年 | 14篇 |
1983年 | 10篇 |
1982年 | 4篇 |
1981年 | 7篇 |
1980年 | 7篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1976年 | 4篇 |
1974年 | 5篇 |
1967年 | 3篇 |
1964年 | 3篇 |
排序方式: 共有2142条查询结果,搜索用时 0 毫秒
21.
This study was undertaken to compare the effect of supraphysiological doses of thyroxine (T4) on bone metabolism in SHAM
and OVX young adult rats. Female Sprague Dawley rats (220 ± 2 g, approx. 5 months of age) were divided into four groups of
eight animals each. The animals were intraperitoneally injected 6 days per week with vehicle (Vh): 0.001 N NaOH/0.9% NaCl
(SHAM+Vh and OVX+Vh) or 250 μg of thyroxine/kg/day (SHAM+T4 and OVX+T4) during a 5-week period. Serum T4 and osteocalcin (BGP),
urinary pyridinolines (Pyr), and creatinine (creat) were determined. At the beginning and at end of the experiment, skeletal
bone mineral content (BMC), bone mineral density (BMD), and area (A) of the total skeleton, femur, spine, and whole tibia,
as well as proximal, middle, and distal areas of the tibia were assessed by dual X-ray absorptiometry (DXA) in an ultra-high-resolution
mode. T4 treatment of the SHAM rats did not induce significant changes in BGP level or Pyr/creat excretion compared with the
SHAM+Vh control group. However, these two biochemical bone markers significantly increased due to T4 treatment in OVX rats
compared with both OVX+Vh and SHAM+T4 groups (P < 0.05 and P < 0.001, respectively). The OVX+T4 group had a significantly lower ΔBMD than SHAM+T4 rats in all studied regions (P < 0.05) except for the middle tibia region. OVX+T4 groups presented a significantly lower ΔBMC and ΔA compared with SHAM+T4
animals (P < 0.001). OVX+T4 rats significantly impaired the ΔBMD in the femur (P < 0.01), spine (P < 0.05), whole (P < 0.05) and middle (P < 0.05) tibia whereas T4 treatment of SHAM rats only affected, significantly, the whole (P < 0.05) and the proximal tibia region (P < 0.01). T4 treatment affects bone growth in young adult rats. The effect is significantly greater in the estrogen-depleted
than in the estrogen-repleted state. The bone site most adversely affected by T4 treatment depends on the estrogen status.
The proximal tibia (principally trabecular bone) was the most affected area in estrogen-repleted rats. Conversely, in OVX
rats, the middle tibia (principally cortical bone) presented the greatest decrease in bone density.
Received: 20 May 1999 / Accepted: 4 February 2000 相似文献
22.
Alejandra Carretero-Krug Natalia úbeda Carlos Velasco Juan Medina-Font Trinidad Trujillo Laguna Gregorio Varela-Moreiras Ana Montero 《军事医学研究(英文)》2022,(2):184-192
Background: An adequate hydration status is critical to ensure efficiency during mental and physical activities.Our goal was to assess the hydration status of a Spanish group of aeronautical military men and to determine the association of hydration status with body composition and anxiety.Methods: A total of 188 men were evaluated through a validated hydration questionnaire, anthropometric and biochemical parameters, and an anxiety questionnaire. Based on these methods, the criteria of hydratio... 相似文献
23.
Michela Fresina Anna Dickmann Annabella Salerni Fabio De Gregorio Emilio C. Campos 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2008,246(1):143-150
Purpose The purpose of the study was to evaluate the effect on visual function of orally administered CDP-choline in addition to patching
for the treatment of amblyopia in children.
Methods This was an open label parallel group study comparing patching plus oral CDP-choline with patching alone. Sixty-one participants
(aged between 5 and 10 years) suffering from anisometropic or strabismic amblyopia were divided at random into two groups:
Group A, 800 or 1,200 mg (according to the body weight) of orally administered CDP-choline and 2-h patching a day; Group B,
2-h patching a day. Both groups were treated for 30 consecutive days. A follow-up visit was set 60 days after the treatment
was discontinued. The main outcome measure was the change in visual acuity of amblyopic eyes as measured by Snellen’s E charts.
The secondary outcome measures were changes in the visual acuity of amblyopic eye as measured by isolated letters (Snellen’s
E) and changes in the contrast sensitivity of amblyopic eyes.
Results The addition of CDP-choline to patching therapy was not found to be more effective than patching alone after 30-day treatment.
The present results showed that adding CDP-choline to patching stabilised the effects obtained during the treatment period.
In fact, whereas the participants treated only with patching showed a decrease in visual acuity at 90 days, these receiving
CDP-choline and patching combined appeared to maintain the results obtained (two-way ANOVA: P = 0.0042). Similar results were obtained when measuring visual acuity by isolated Snellen’s E letters.
Conclusions In amblyopic patients, CDP-choline combined with patching contributes to obtaining more stable effects than patching alone.
Fabio De Gregorio works as an advisor for Tubilux Pharma S.p.A.
The authors have full control of all primary data and they agree to allow Graefe’s Archives for Clinical and Experimental Ophthalmology to review their data if requested. 相似文献
24.
25.
Translumbar retroperitoneal endoscopy: an alternative in the follow-up and management of drained infected pancreatic necrosis 总被引:4,自引:0,他引:4
Castellanos G Piñero A Serrano A Llamas C Fuster M Fernandez JA Parrilla P 《Archives of surgery (Chicago, Ill. : 1960)》2005,140(10):952-955
BACKGROUND: The follow-up of drained infected pancreatic necrosis (IPN) is usually done with data on the patient's clinical evolution and information obtained from serial helical computed tomographic scans. Management often requires necrosectomies and periodic debridements. HYPOTHESIS: Translumbar retroperitoneal endoscopy is effective in the management of drained IPN. DESIGN: A prospective observational study. SETTING: University tertiary care hospital. PATIENTS: A series of 11 consecutive patients with drained IPN undergoing postoperative follow-up with translumbar retroperitoneal endoscopy. INTERVENTIONS: Initially, the IPN was drained via the posterior extraperitoneal translumbar approach; then, a superficial necrosectomy was performed during the same surgical intervention by flushing and endoscopic aspiration; and, finally, a lavage and drainage system was fitted. In the immediate postoperative period, for management of the IPN, we removed the drainage tube and inserted a flexible endoscope as far as the pancreatic area to eliminate the infected necrotic material by flushing and aspiration. MAIN OUTCOME MEASURES: In these patients, we studied control of the infection of the pancreatic area, quantification variables of the necrosectomy, technique-related morbidity and mortality, and the need for subsequent operations. RESULTS: The 11 patients studied showed good results regarding the control and complete elimination of the infected necrosis. There was no technique-related morbidity or mortality or need for subsequent operations. CONCLUSION: Translumbar retroperitoneal endoscopy allows exploration of the retroperitoneal space under direct visual guidance, facilitates lavage and aspiration, avoids subsequent surgical operations for debridement, decreases the need for repeated computed tomographic scans to evaluate the evolution of the IPN, and has no added morbidity or mortality. 相似文献
26.
Daltro C Gregorio PB Alves E Abreu M Bomfim D Chicourel MH Araújo L Cotrim HP 《Obesity surgery》2007,17(6):809-814
Background Obesity is the most important risk factor for obstructive sleep apnea. It is estimated that 70% of sleep apnea patients are
obese. In the morbidly obese, the prevalence may reach 80% in men and 50% in women. The aim of this study was to determine
the prevalence and severity of sleep apnea in a group of morbidly obese patients, leading to bariatric surgery.
Methods In a cross-sectional study developed in Bahia, northeastern Brazil. 108 patients (78 women and 30 men) from the Obesity Treatment
and Surgery Center - “Núcleo de Tratamento e Cirurgia da Obesidade” underwent standard polysomnography. Patients with an apnea-hypopnea
index (AHI) ≥ 5 events/hour were considered apneic.
Results Mean ± SD for age and BMI were 37.1 ± 10.2 years and 45.2 ± 5.4 kg/m2, respectively. The calculated AHI ranged widely from
2.5 to 128.9 events/hour. Sleep apnea was detected in 93.6% of the sample, wherein 35.2% had mild, 30.6% moderate and 27.8%
severe apnea. Oxyhemoglobin desaturation was directly related to the AHI and was more severe in men.
Conclusion There was a high frequency of sleep apnea in this group of morbidly obese patients, for whom it was very important to request
polysomnography, thus enabling therapeutic management and prognostication. 相似文献
27.
28.
29.
30.
Bravo MJ Vallejo F Barrio G Brugal MT Molist G Pulido J Sordo L de la Fuente L;the ITINERE Project Group 《The International journal on drug policy》2012,23(5):415-419
BACKGROUND: Heroin users who do not inject constitute a large pool of drug users with a potentially important impact on public health. We aimed to estimate the incidence of hepatitis C virus (HCV) among heroin users who had never injected (NIDUS) at baseline, and the effect of starting injecting during follow-up, other percutaneous exposures, sharing snorting paraphernalia, cocaine/crack use, and risky sexual behaviour on HCV-seroconversion. METHODS: Prospective cohort of 305 HCV-negative NIDUs at baseline, aged 18-30 and street-recruited in three Spanish cities in 2001-2003. Computer-assisted personal interviews were conducted and dried blood-spot samples were collected. Bivariate and multivariable Poisson models were used. RESULTS: Among the 305 never-injectors who were HCV-negative at baseline, 197 (64.6%) were followed-up and 21 seroconverted [HCV-incidence rate=5.8/100 person-years at risk (pyar) (95% CI: 3.6-8.9)]. HCV incidence in new-injectors was 28.4/100pyar [(95% CI, 14.7-49.7) vs. 2.8/100pyar (95% CI, 1.3-5.4)] among NIDUs. Of the risk exposures considered, starting injecting was the only predictor of HCV-seroconversion [adjusted relative risk=10.1, 95% CI: 3.8-26.7]. CONCLUSION: The HCV-seroconversion rate was 10 times higher among new-injectors than never-injectors. No predictors other than starting injecting were found for HCV-seroconversion. Harm reduction interventions to prevent HCV infection should include prevention of drug injection. 相似文献